
Biotech’s DeepSeek moment: Hong Kong investor ORI sees opportunity in China with new fund
Hong Kong-based venture capital firm ORI Capital plans to launch a new fund to invest in Chinese healthcare start-ups, as the domestic biotechnology industry experiences its own “DeepSeek moment”, its founder said in an interview. ORI, established in 2015 …